期刊文献+

重组人乳头瘤病毒16型L1 VLP的初步纯化、鉴定及免疫效果的初步研究

A preliminary study on purification, identification and immunogenicity of HPV16 L1 VLPs
原文传递
导出
摘要 目的 对昆虫细胞-杆状病毒系统表达的人乳头瘤病毒(human papillomavirus,HPV)16型L1蛋白病毒样颗粒(virus-like particle,VLP)进行初步纯化研究,并在小鼠中检测纯化VLP的免疫原性.方法 采用蔗糖-氯化铯密度梯度超速离心纯化方法纯化HPV16 LI VLP.对纯化得到的VLP分别进行蛋白印迹法、十二烷基硫酸钠一聚丙烯酰胺凝胶电泳(SDS-PAGE)及电镜鉴定.然后用VLP免疫6周龄BALB/c小鼠.将小鼠随机分成6组(3个剂量组、2个佐剂组和1个对照组),间隔2周免疫3次,3次剂量相同.取血分离血清,采用间接ELISA法检测抗HPV16 L1 VLP抗体滴度.结果 经蔗糖-氯化铯密度梯度超速离心纯化后,用SDS-PAGE鉴定纯化的HPV16 LI VLP,纯度达到90%.电镜观察可见完整的VLP颗粒.间接EUSA检测结果显示,剂量组及佐剂组小鼠血清中均可检测到特异性抗HPV16 L1 VLP抗体,且抗体滴度随针次和剂量的增加而增高.结论 采用蔗糖-氯化铯密度梯度超速离心纯化法得到的HPV16 L1 VLP可用于免疫学初步研究.通过昆虫细胞表达产生的HPV16 LI VLP 具有较强的免疫原性,能诱导小鼠产生强的体液免疫应答. Objective To study a preliminary purification technique of human papillomavims 16 (HPVl6)L1 protein virus-like particles(VLPs) expressed in insect cell-baculovirus system and the immunogenicity of the purified VLPs in mice.Methods HPV16 L1 VLPs were purified by CsC1 and sucrose density gradient ultracentrifugation,and the purified VLPs were identified by Western blot,sodium dodecyl sulfate polyacrylamide gel electrophoresis(SDS-PAGE)and electron microscopy.Six-week-old BALB/c mice were randomly divided into 6 groups,including 3 dose groups,2 adjuvant groups and a control group,and vaccinated with the purified VLPs 3 times at intervals of 2 weeks.Sera were taken and determined for anti-L1 antibodies by indirect ELISA.Results The purity of HPV16 L1 VLPs was up to 90% by SDS-PAGE identification.Intact VLPs were observed under the electron microscope.Anti-L1 antibodies were detected by ELISA in all dose groups and adjuvant groups.The titers of antibodies increased with vaccination times and dosage.Conclusion The HPV16 L1 VLPs expressed in insect cell-baculovirus system and purified by CsC1 and sucrose density gradient ultracentrifugation have immunogenicity and can induce strong humoral immune responses in mice.
出处 《国际生物制品学杂志》 CAS 2010年第4期169-172,共4页 International Journal of Biologicals
基金 国家高技术研究发展计划(2007AA02Z475)
关键词 人乳头瘤病毒16 L1蛋白 病毒样颗粒 纯化 免疫原性 Human papillomavirus 16 L1 protein Virus-like particles Purification Immunogenicity
  • 引文网络
  • 相关文献

参考文献5

  • 1Roden RB,Hubbert NL,Kirnbauer R,et al.Assessment of the serological relatedness of genital human papillomaviruses by hemagglutination inhibition[J].J Virol,1996,70(5):3298-3301.
  • 2Mu(n)oz N,Bosch FX,Castellsagué X,et al.Against which human papillomavirus types shall we vaccinate and screen?The international perspective[J].Int J Cancer,2004,111(2):278-285.
  • 3Wu Y,Chen Y,Li L,et al.Associations of high-risk HPV types and viral load with cervical cancer in China[J].J Clin Virol,2006,35(3):264-269.
  • 4孙丽媛,刘君,张夕燕,丁军颖,张振龙,许雪梅.重组人乳头瘤病毒16型L1蛋白在昆虫细胞中的表达及条件优化研究[J].国际生物制品学杂志,2009,32(2):64-67. 被引量:2
  • 5Harro CD,Pang YY,Roden RB,et al.Safety and immunogenicity trial in adult volunteers of a human papillomavirus 16 L1 viruslike particle vaccine[J].J Natl Cancer Inst,2001,93(4):284-292.

二级参考文献4

  • 1Lowy DR, Schiller JT. Prophylactic human papillomavirus vaccines [J]. J Clin Invest, 2006, 116(5) : 1167-1173.
  • 2Zur Hansen H. Papillomaviruses causing cancer: evasion from host-cell control in early events in carcinogenesis [ J ]. J Natl Cancer Inst, 2000, 92(9) :690-698.
  • 3刘伯玉.HPV疫苗和筛查预防宫颈癌.国际生物制品学杂志,2008,31(2):75-78.
  • 4李秀荣,任宏佳.宫颈癌HPV预防性疫苗研究进展[J].国外医学(免疫学分册),2000,23(5):263-265. 被引量:4

共引文献1

;
使用帮助 返回顶部